Results 291 to 300 of about 162,494 (358)
A substantial proportion of oral drug administrations in children require manipulation due to the lack of age‐appropriate formulations. Common methods such as splitting, crushing, and dispersing tablets in fluids can compromise dose accuracy because of e.g., drug solubility.
M. Paulsson +5 more
wiley +1 more source
Comparative Risk of Major Bleeding With Concomitant Use of Oral Anticoagulants and Corticosteroid Bursts. [PDF]
Yao TC +4 more
europepmc +1 more source
ABSTRACT Objectives Patients receiving antiresorptive medication (AR) for osteoporosis or cancer are at risk of medication‐related osteonecrosis of the jaws (MRONJ), especially after surgical procedures. Dental implant (DI) placement in high‐dose AR (HDAR) patients is widely discouraged, and thorough counseling is recommended for low‐dose AR (LDAR ...
Sanne Werner Moeller Andersen +4 more
wiley +1 more source
Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients. [PDF]
Sunaga A +16 more
europepmc +1 more source
Contraception in Myeloproliferative Neoplasms: A Pharmacological Review
ABSTRACT Myeloproliferative neoplasms (MPNs) are chronic hematologic disorders characterized by clonal proliferation of myeloid lineage cells, commonly driven by JAK2 mutations, and associated with significant thrombotic and hemorrhagic complications.
Awni Alshurafa +4 more
wiley +1 more source
Stroke prevention in atrial fibrillation: Why oral anticoagulation remains the standard over devices. [PDF]
Ruzieh M, Jiao T, Mandrola J, Foy AJ.
europepmc +1 more source
ABSTRACT This state‐of‐the‐art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated ...
Sanjeev Saksena +3 more
wiley +1 more source
Drug-drug interactions: A descriptive analysis of FDA adverse event reporting system. [PDF]
Alahmari A, Fatani S, Ahmed N.
europepmc +1 more source
ABSTRACT Background Vascular recovery from catheter ablation (CA) has traditionally required a period of leg immobilization which can lead to discomfort and prolonged time to discharge. Objective The objective of this study was to compare a strategy of immediate leg mobilization (IM) using suture‐mediated closure devices against traditional vascular ...
Riya Sam +8 more
wiley +1 more source

